The University of Pittsburgh School of Medicine, through the Pittsburgh Vaccine Trials Unit (PVTU), is one of twelve sites across the country selected to participate in a National Institute of Allergy and Infectious Diseases clinical trial in which fully vaccinated adults will receive a third “booster” dose of a COVID-19 vaccine. The trial will study […]